AstraZeneca Earnings, Sales Rise, Beat Forecasts

AstraZeneca, a pharmaceutical company, reported an increase in first-quarter core earnings per share and sales. Core earnings per share rose to $2.06, up from $1.92 in the same period last year. The company’s sales also exceeded forecasts.